1. Home
  2. LIVN

LIVN

LivaNova PLC

Logo LivaNova PLC

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-19-2024 2:31pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.

Founded: 1987 Country:
United Kingdom
United Kingdom
Employees: N/A City: LONDON
Market Cap: 2.8B IPO Year: 1993
Target Price: $64.00 AVG Volume (30 days): 645.7K
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.32 EPS Growth: N/A
52 Week Low/High: $42.47 - $59.86 Next Earning Date: 05-01-2024
Revenue: $1,153,545,000 Revenue Growth: 12.89%
Revenue Growth (this year): 6.89% Revenue Growth (next year): 4.70%

Share on Social Networks: